These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 2452522
1. Potentiation of DNA damage and cytotoxicity by calmodulin antagonists. Rosenthal SA, Hait WN. Yale J Biol Med; 1988; 61(1):39-49. PubMed ID: 2452522 [Abstract] [Full Text] [Related]
4. Increased growth inhibition and DNA lesions in human colon adenocarcinoma cells treated with methotrexate or 5-fluorodeoxyuridine followed by calmodulin inhibitors. Lönn U, Lönn S. Cancer Res; 1988 Jun 15; 48(12):3319-23. PubMed ID: 2453268 [Abstract] [Full Text] [Related]
5. Calmodulin antagonist W 13 prevents DNA repair after bleomycin treatment of human urological tumor cells growing on extracellular matrix. Pavelić K. Int J Biochem; 1987 Jun 15; 19(11):1091-5. PubMed ID: 2448175 [Abstract] [Full Text] [Related]
6. Lidocaine potentiation of bleomycin A2 cytotoxicity and DNA strand breakage in L1210 and human A-253 cells. Lazo JS, Braun ID, Meandzija B, Kennedy KA, Pham ET, Smaldone LF. Cancer Res; 1985 May 15; 45(5):2103-9. PubMed ID: 2580616 [Abstract] [Full Text] [Related]
7. Cytotoxicity, calmodulin and DNA lesions in cells treated with streptozotocin. Lönn U, Lönn S. Biochem Pharmacol; 1988 Sep 15; 37(18):3441-6. PubMed ID: 2971359 [Abstract] [Full Text] [Related]
8. Potentiation of sensitivity to bleomycin and the drug-induced DNA damage in EMT6 cells by the calmodulin inhibitor trifluoperazine. Smith PJ, Mircheva JJ, Bleehen NM. Acta Physiol Pharmacol Bulg; 1987 Sep 15; 13(1):41-5. PubMed ID: 2441572 [Abstract] [Full Text] [Related]
10. W-7, a calmodulin inhibitor, potentiates dacarbazine cytotoxicity in human neoplastic cells. Lönn U, Lönn S. Int J Cancer; 1987 May 15; 39(5):638-42. PubMed ID: 3570556 [Abstract] [Full Text] [Related]
11. Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumor cells. Smith PJ, Mircheva J, Bleehen NM. Int J Radiat Oncol Biol Phys; 1986 Aug 15; 12(8):1363-6. PubMed ID: 2428790 [Abstract] [Full Text] [Related]
12. Potentiation of bleomycin cytotoxicity in cultured mammalian cells by polyacrylic acid. III. Induction of DNA strand breakage and suppression of cellular heat production. Sarai K, Kohda K, Hayatsu H, Miyamae T, Kawazoe Y. Anticancer Res; 1991 Aug 15; 11(2):957-60. PubMed ID: 1712183 [Abstract] [Full Text] [Related]
15. Targeting calmodulin for the development of novel cancer chemotherapeutic agents. Hait WN. Anticancer Drug Des; 1987 Oct 15; 2(2):139-49. PubMed ID: 3329523 [Abstract] [Full Text] [Related]
16. Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: I. In vitro cytotoxicity. Mircheva J, Smith PJ, Bleehen NM. Br J Cancer; 1986 Jan 15; 53(1):99-103. PubMed ID: 2418860 [Abstract] [Full Text] [Related]
17. A calmodulin antagonist has no effect on the repair of X-ray-induced damage in a murine mammary carcinoma cell line. Ridinger DN, Loh SN, Warters RL, Dethlefsen LA. Radiat Res; 1986 Nov 15; 108(2):127-38. PubMed ID: 3786673 [Abstract] [Full Text] [Related]
18. Comparison between X-rays and SR 4233 for cytotoxicity and repair of potentially lethal damage in human cells. Biedermann KA, Brown JM. Int J Radiat Biol; 1989 Nov 15; 56(5):813-6. PubMed ID: 2573680 [No Abstract] [Full Text] [Related]
19. Naringin, a grapefruit flavanone, protects V79 cells against the bleomycin-induced genotoxicity and decline in survival. Jagetia A, Jagetia GC, Jha S. J Appl Toxicol; 2007 Nov 15; 27(2):122-32. PubMed ID: 17177233 [Abstract] [Full Text] [Related]
20. Increased lethality of calmodulin antagonists and bleomycin to human bone marrow and bleomycin-resistant malignant cells. Lazo JS, Chen DL, Gallicchio VS, Hait WN. Cancer Res; 1986 May 15; 46(5):2236-40. PubMed ID: 2421873 [Abstract] [Full Text] [Related] Page: [Next] [New Search]